Lantus vs Basaglar
Basaglar is a biosimilar to Lantus with the same insulin glargine at lower cost. They are clinically interchangeable.
Side-by-Side Comparison
| Lantus | Basaglar | |
|---|---|---|
| Generic Name | Insulin Glargine | Insulin Glargine |
| Manufacturer | Sanofi | Eli Lilly |
| FDA Uses | Type 1 diabetes, Type 2 diabetes | Type 1 diabetes, Type 2 diabetes |
| Dosing | Once daily, same time each day | Once daily, same time each day |
| Monthly Cost | $310 | $240 |
| With Insurance | $10–$75 | $10–$60 |
| Common Side Effects | Injection site reactions, Weight gain | Injection site reactions, Weight gain |
Check what benefits you qualify for
Answer 9 questions. See every program you're eligible for. Free.
Frequently Asked Questions
Which is better, Lantus or Basaglar?
Basaglar is a biosimilar to Lantus with the same insulin glargine at lower cost. They are clinically interchangeable. The best choice depends on your specific condition, insurance coverage, and how your body responds. Talk to your doctor about which is right for you.
Is Lantus cheaper than Basaglar?
Lantus costs $310/month while Basaglar costs $240/month without insurance. With insurance, copays may be similar depending on your plan's formulary.
Can I switch from Lantus to Basaglar?
Switching between these medications should only be done under your doctor's supervision. They may need to adjust dosing and monitor for side effects during the transition.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.